Idiopathic growth hormone deficiency: A vanishing diagnosis?

Hormone Research

Volumn 53, Issue SUPPL. 3, 2000, Pages 1-8

  Pfäffle, Roland ^a   Blankenstein, Oliver ^a   Wüller, Stephan ^a   Heimann, Konrad ^a   Heimann, G ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

Combined growth hormone deficiency; Growth hormone; Growth hormone releasing hormone; HesX1; Isolated growth hormone deficiency; P Lim; Pit 1; Prop 1

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RELEASING FACTOR; GROWTH HORMONE RELEASING FACTOR RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR PIT 1;

ADENOHYPOPHYSIS DISEASE; CONFERENCE PAPER; GENE DELETION; GENE LOCUS; GENE MUTATION; GENETIC TRANSCRIPTION; GROWTH HORMONE DEFICIENCY; HORMONE DEFICIENCY; HUMAN; HYPOTHALAMUS HYPOPHYSIS SYSTEM; IDIOPATHIC DISEASE; NONHUMAN; PRIORITY JOURNAL;

EID: 17544388568     PISSN: 03010163     EISSN: None     Source Type: Journal    
DOI: 10.1159/000023524     Document Type: Conference Paper

References (53)

1. Lacey KA, Parkin JM: Causes of short stature. A community study of children in Newcastle upon Tyne. Lancet 1974;i:42-45.
2. Vimpani GV, Vimpani AF, Lidgard GP, Cameron EH, Farquhar JW: Prevalence of severe growth hormone deficiency. Br Med J 1977;2: 427-430.
3. Phillips JA: Inherited defects in growth hormone synthesis and action: in Scriver CR, Beaudet AL, Sly WS, Valle D (eds): The Metabolic Basis of Inherited Disease. New York, McGraw-Hill, 1995, vol 3, pp 3023-3044.
4. Wilton P, Wallstrom A: An overview of the diagnoses in the Kabi Pharmacia International Growth Study. Acta Pediatr Scand Suppl 1991;379:93-98.
5. Procter AM, Phillips JA 3rd, Cooper DN: The molecular genetics of growth hormone deficiency. Hum Genet 1998;103:255-272.
6. Chen EY, Liao YC, Smith DH, Barrera-Saldana HA, Gelinas RE, Seeburg PH: The human growth hormone locus: Nucleotide sequence, biology, and evolution. Genomics 1989;4:479-497.
7. Phillips JAD, Beamer WG, Bartke A: Analysis of growth hormone genes in mice with genetic defects of growth hormone expression. J Endocrinol 1982;92:405-407.
8. Akinci A, Kanaka C, Eble A, Akar N, Vidinlisan S, Mullis PE: Isolated growth hormone (GH) deficiency type IA associated with a 45-kilobase gene deletion within the human GH genet cluster. J Clin Endocrinol Metab 1992;75: 437-441.
9. Cacciari E, Pirazzoli P, Gualandi S, Baroncini C, Baldazzi L, Trevisani B, Capelli M, Zucchini S, Balsamo A, Cicognani A, et al: Molecular study of human growth hormone gene cluster in three families with isolated growth hormone deficiency and similar phenotype. Eur J Pediatr 1994;153:635-641.
10. Wagner JK, Eble A, Hindmarsh PC, Mullis PE: Prevalence of human GH-1 gene alterations in patients with isolated growth hormone deficiency. Pediatr Res 1998;43:105-110.
11. Illig R: Growth hormone antibodies in patients treated with different preparations of human growth hormone (HGH). J Clin Endocrinol Metab 1970;31:679-688.
12. Laron Z, Kelijman M, Pertzelan A, Keret R, Shoffner JM, Parks JS: Human growth hormone gene deletion without antibody formation or growth arrest during treatment - A new disease entity? Isr J Med Sci 1985;21:999-1006.
13. Hauffa BP, Illig R, Torresani T, Stolecke H, Phillips JAD: Discordant immune and growth response to pituitary and biosynthetic growth hormone in siblings with isolated growth hormone deficiency type IA. Acta Endocrinol (Copenh) 1989;121:609-614.
14. Igarashi Y, Ogawa M, Kamijo T, Iwatani N, Nishi Y, Kohno H, Masumura T, Koga J: A new mutation causing inherited growth hormone deficiency: A compound heterozygote of a 6.7 kb deletion and a two base deletion in the third exon of the GH-1 gene. Hum Mol Genet 1993;2:1073-1074.
15. Binder G, Ranke MB: Screening for growth hormone (GH) gene splice-site mutations in sporadic cases with severe isolated GH deficiency using ectopic transcript analysis. J Clin Endocrinol Metab 1995;80:1247-1252.
16. Cogan JD, Ramel B, Lehto M, Phillips JA Jr, Prince M, Blizzard RM, de Ravel TJ, Brammert M, Groop L: A recurring dominant negative mutation causes autosomal dominant growth hormone deficiency - A clinical research center study. J Clin Endocrinol Metab 1995;80:3591-3595.
17. Binder G, Brown M, Parks JS: Mechanisms responsible for dominant expression of human growth hormone gene mutations. J Clin Endocrinol Metab 1996;81:4047-4050.
18. Mitrakou A, Hadjidakis G, Raptis S, Bartsocas CS, Souvatzoglou A: Heterogeneity of growth-hormone deficiency. Lancet 1985;i:399-400.
19. Mullis P, Patel M, Brickell PM, Brook CG: Isolated growth hormone deficiency: Analysis of the growth hormone (GH)-releasing hormone gene and the GH gene cluster. J Clin Endocrinol Metab 1990;70:187-191.
20. Gaylinn BD, Harrison JK, Zysk JR, Lyons CE, Lynch KR, Thorner MO: Molecular cloning and expression of a human anterior pituitary receptor for growth hormone-releasing hormone. Mol Endocrinol 1993;7:77-84.
21. Godfrey P, Rahal JO, Beamer WG, Copeland NG, Jenkins NA, Mayo KE: GHRH receptor of little mice contains a missense mutation in the extracellular domain that disrupts receptor function. Nat Genet 1993;4:227-232.
22. Wajnrajch MP, Gartner JM, Harbison MD, Chua SC Jr, Leibel RL: Nonsense mutation in the human growth hormone-releasing hormone receptor causes growth failure analogous to the little (lit) mouse. Nat Genet 1996;12:88-90.
23. Maheshwari HG, Silverman BL, Dupuis J, Baumann G: Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. J Clin Endocrinol Metab 1998;83:4065-4074.
24. Netchine I, Talon P, Dastot F, Vitaux F, Goossens M, Amselem S: Extensive phenotypic analysis of a family with growth hormone (GH) deficiency caused by a mutation in the GH-releasing hormone receptor gene. J Clin Endocrinol Metab 1998;83:432-436.
25. Rosenfeld MG, Bach I, Erkman L, Li P, Lin C, Lin S, McEvilly R, Ryan A, Rhodes S, Schonnemann M, Scully K: Transcriptional control of cell phenotypes in the neuroendocrine system. Recent Prog Horm Res 1996;51:217-238.
26. Gehring WJ, Hiromi Y: Homeotic genes and the homeobox. Annu Rev Genet 1986;20:147-173.
27. Ingraham HA, Chen RP, Mangalam HJ, Elsholtz HP, Flynn SE, Lin CR, Simmons DM, Swanson L, Rosenfeld MG: A tissue-specific transcription factor containing a homeodomain specifies a pituitary phenotype. Cell 1988;55:519-529.
28. Argenton F, Vianello S, Bernardini S, Jacquemin P, Martial J, Belayew A, Colombo L, Bortolussi M: The transcriptional regulation of the growth hormone gene is conserved in vertebrate evolution. Biochem Biophys Res Commun 1993;192:1360-1366.
29. Simmons DM, Voss JW, Ingraham HA, Holloway JM, Broide RS, Rosenfeld MG, Swanson LW: Pituitary cell phenotypes involve cell-specific Pit-1 mRNA translation and synergistic interactions with other classes of transcription factors. Genes Dev 1990;4:695-711.
30. Duquesnoy RJ: The pituitary dwarf mouse: A model for study of endocrine immunodeficiency disease. Birth Defects Orig Artic Ser 1975; 11:536-543.
31. Li S, Crenshaw EBD, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG: Dwarf locus mutants lacking three pituitary cell types result from mutations in the POU-domain gene Pit-1. Nature 1990;347:528-533.
32. Pfäffle RW, Kim C, Otten B, Wit JM, Eiholzer U, Heimann G, Parks J: Pit-1: Clinical aspects. Horm Res 1996;45:25-28.
33. Tatsumi K, Miyai K, Notomi T, Kaibe K, Amino N, Mizuno Y, Kohno H: Cretinism with combined hormone deficiency caused by a mutation in the PIT1 gene. Nat Genet 1992;1:56-58.
34. Pfäffle RW, DiMattia GE, Parks JS, Brown MR, Wit JM, Jansen M, Van der Nat H, Van den Brande JL, Rosenfeld MG, Ingraham HA: Mutation of the POU-specific domain of Pit-1 and hypopituitarism without pituitary hypoplasia. Science 1992;257:111-1121.
35. Radovick S, Nations M, Du Y, Berg LA, Weintraub BD, Wondisford FE: A mutation in the POU-homeodomain of Pit-1 responsible for combined pituitary hormone deficiency. Science 1992;257:1115-1118.
36. Ohta K, Nobukuni Y, Mitsubuchi H, Fujimoto S, Matsuo N, Inagaki H, Endo F, Matsuda I: Mutations in the Pit-1 gene in children with combined pituitary hormone deficiency. Biochem Biophys Res Commun 1992;189:851-855.
37. Buckwalter MS, Katz RW, Camper SA: Localization of the panhypopituitary dwarf mutation (df) on mouse chromosome 11 in an intersubspecific backeross. Genomics 1991;10:515-526.
38. Sornson MW, Wu W, Dasen JS, Flynn SE, Norman DJ, O'Connell SM, Gukovsky I, Carriere C, Ryan AK, Miller AP, Zuo L, Gleiberman AS, Andersen B, Beamer WG, Rosenfeld MG: Pituitary lineage determination by the Prophet of Pit-1 homeodomain factor defective in Ames dwarfism. Nature 1996;384:327-333.
39. Wu W, Cogan JD, Pfäffle RW, Dasen JS, Frisch H, SM OC, Flynn SE, Brown MR, Mullis PE, Parks JS, Phillips JAR, Rosenfeld MG: Mutations in PROP1 cause familial combined pituitary hormone deficiency. Nat Genet 1998; 18:147-149.
40. Fofanova O, Takamura N, Kinoshita E, Parks JS, Brown MR, Peterkova VA, Evgrafov OV, Goncharov NP, Bulatov AA, Dedov II, Yamashita S: Compound heterozygous deletion of the PROP-1 gene in children with combined pituitary hormone deficiency. J Clin Endocrinol Metab 1998;83:2601-2604.
41. Fluck C, Deladoey J, Rutishauser K, Eble A, Marti U, Wu W, Mullis PE: Phenotypic variability in familial combined pituitary hormone deficiency caused by a PROP1 gene mutation resulting in the substitution of Arg→Cys at codon 120 (R120C). J Clin Endocrinol Metab 1998;83:3727-3734.
42. Fofanova O, Takamura N, Kinoshita E, Vorontsov A, Vladimirova V, Dedov I, Peterkova V, Yamashita S: MR imaging of the pituitary gland in children and young adults with congenital combined pituitary hormone deficiency associated with PROP1 mutations. Am J Roentgenol 2000;174:555-559.
43. Pfäffle RW, Blankenstein O, Wüller S, Kentrup H: Combined pituitary hormone deficiency: Role of Pit-1 and Prop-1. Acta Paediatr Suppl 1999;88:33-41.
44. Mendonca BB, Osorio MG, Latronico AC, Estefan V, Lo LS, Arnhold IJ: Longitudinal hormonal and pituitary imaging changes in two females with combined pituitary hormone deficiency due to deletion of A301,G302 in the PROP1 gene. J Clin Endocrinol Metab 1999; 84:942-945.
45. Rosenbloom AL, Almonte AS, Brown MR, Fisher DA, Baumbach L, Parks JS: Clinical and biochemical phenotype of familial anterior hypopituitarism from mutation of the PROP1 gene. J Clin Endocrinol Metab 1999;84:50-57.
46. Dattani MT, Martinez-Barbera JP, Thomas PQ, Brickman JM, Gupta R, Martensson IL, Toresson H, Fox M, Wales JK, Hindmarsh PC, Krauss S, Beddington RS, Robinson IC: Mutations in the homeobox gene HESX1/HesX1 associated with septo-optic dysplasia in human and mouse. Nat Genet 1998;19:125-133.
47. Dattani M, Brickmann J, Tyrrell R, Dunger D, Woods K, Hurst J, Hindmarsh P, Thomas P, Beddington R, Robinson I: Novel mutations of HesX1 associated with septo-optic dysplasia in man (abstract). Horm Res 1999;51(suppl 2): 32.
48. Bach I, Rhodes SJ, Pearse RVN, Heinzel T, Gloss B, Scully KM, Sawchenko PE, Rosenfeld MG: P-Lim, a LIM homeodomain factor, is expressed during pituitary organ and cell commitment and synergizes with Pit-1. Proc Natl Acad Sci USA 1995;92:2720-2724.
49. Bach I, Carriere C, Ostendorff HP, Andersen B, Rosenfeld MG: A family of LIM domain-associated cofactors confer transcriptional synergism between LIM and Otx homeodomain proteins. Genes Dev 1997;11:1370-1380.
50. Sheng HZ, Zhadanov AB, Mosinger B Jr, Fujii T, Bertuzzi S, Grinberg A, Lee EJ, Huang SP, Mahon KA, Westphal H: Specification of pituitary cell lineages by the LIM homeobox gene Lhx3. Science 1996;272:1004-1007.
51. Zhadanov AB, Bertuzzi S, Taira M, Dawid IB, Westphal H: Expression pattern of the murine LIM class homeobox gene Lhx3 in subsets of neural and neuroendocrine tissues. Dev Dyn 1995;202:354-364.
52. Sheng HZ, Moriyama K, Yamashita T, Li H, Potter SS, Mahon KA, Westphal H: Multistep control of pituitary organogenesis. Science 1997;278:1809-1812.
53. Mullis PE, Akinci A, Kanaka C, Eble A, Brook CG: Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatr Res 1992;31:532-534.